JAK/STAT Signaling


Various ligands including cytokines (e.g. interferons and interleukins), hormones (e.g. erythropoietin and growth hormone) and their cell surface receptors activate JAK proteins, which autophosphorylate, and then phosphorylate the receptor. Subsequently, JAKs phosphorylate a specific tyrosine residue on the STAT protein, promoting dimerization via SH2 domains. The activated STATs form homo-/heterodimers and translocate to the nucleus to trigger target gene transcription. In addition, suppressors of cytokine signaling (SOCS) family inhibit receptor signaling via homologous or heterologous feedback regulation. Dysregulation in JAK/STAT signaling is associated with diseases such as atherosclerosis, immunodeficiencies and cancer.
-
BA2996 UC-514321Summary: A selective TET1 inhibitor -
BA6006 CirsilineolSummary: Cirsilineol is a natural flavonoid compound that selectively inhibits IFN-γ/STAT1/T-bet signaling in intestinal T cells. -
BA6391 DHFR-IN-4Summary: DHFR-IN-4 is a potent dihydrofolate reductase inhibitor. -
BA6423 3-DemethylnobiletinSummary: 3'-Demethylnobiletin is a derivative of Nobiletin, 3'-Demethylnobiletin is a polymethoxyflavonoid present in citrus fruits. -
BA6455 HirsutenoneSummary: Hirsutenone, an active diheptanone contained in alder, has a variety of biological activities including anti-inflammatory, anti-tumor and anti-atopic dermatitis. -
BA2725 C188-9Summary: C188-9 (TTI-101) is an inhibitor. -
BA2752 AC-4-130Summary: AC-4-130 is a potent structural domain inhibitor. -
BA2753 SD-36Summary: SD-36 is an effective degradant (=~50nM) with high selectivity compared to other members. -
BA2797 STAT3-IN-1Summary: STAT3-IN-1 is a potent, selective, and orally effective inhibitor with values of 1.82 μM and 2.14 μM in HT29 and MDA-MB231 cells, respectively. -
BA2806 SC-43Summary: SC-43, a derivative of Sorafenib, is a potent agonist with oral activity.

